The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
BCG Vaccine-Global Market Insights and Sales Trends 2025
Synopsis
BCG Vaccine is a vaccine primarily used against tuberculosis. Tuberculosis is a serious infection, which affects the lungs and sometimes other parts of the body, such as the bones, joints and kidneys. The bacille Calmette-Guérin (BCG) vaccine has existed for 80 years and is one of the most widely used of all current vaccines, reading >80%of neonates and infants in countries where it is part of the national childhood immunization programme.
The global BCG Vaccine market size is expected to reach US$ 549.7 million by 2029, growing at a CAGR of 5.6% from 2023 to 2029. The market is mainly driven by the significant applications of BCG Vaccine in various end use industries. The expanding demands from the Hospitals, Clinics and Others,, are propelling BCG Vaccine market. Immune BCG, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Therapy BCG segment is estimated at % CAGR for the next seven-year period.
Japan is the largest BCG Vaccine market with about 30% market share. North America is follower, accounting for about 29% market share.The key manufacturers are Merck, Sanofi Pasteur, Japan BCG Lab, China National Biotec, Serum Institute of India, Intervax, GSBPL etc. Top 3 companies occupied about 77% market share.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for BCG Vaccine, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global BCG Vaccine market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global BCG Vaccine market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, BCG Vaccine sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of BCG Vaccine covered in this report include Merck, Sanofi Pasteur, Japan BCG Lab, China National Biotec, Serum Institute of India, Intervax and GSBPL, etc.
The global BCG Vaccine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Merck
Sanofi Pasteur
Japan BCG Lab
China National Biotec
Serum Institute of India
Intervax
GSBPL
Global BCG Vaccine market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global BCG Vaccine market, Segment by Type:
Immune BCG
Therapy BCG
Global BCG Vaccine market, by Application
Hospitals
Clinics
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of BCG Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of BCG Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
BCG Vaccine is a vaccine primarily used against tuberculosis. Tuberculosis is a serious infection, which affects the lungs and sometimes other parts of the body, such as the bones, joints and kidneys. The bacille Calmette-Guérin (BCG) vaccine has existed for 80 years and is one of the most widely used of all current vaccines, reading >80%of neonates and infants in countries where it is part of the national childhood immunization programme.
The global BCG Vaccine market size is expected to reach US$ 549.7 million by 2029, growing at a CAGR of 5.6% from 2023 to 2029. The market is mainly driven by the significant applications of BCG Vaccine in various end use industries. The expanding demands from the Hospitals, Clinics and Others,, are propelling BCG Vaccine market. Immune BCG, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Therapy BCG segment is estimated at % CAGR for the next seven-year period.
Japan is the largest BCG Vaccine market with about 30% market share. North America is follower, accounting for about 29% market share.The key manufacturers are Merck, Sanofi Pasteur, Japan BCG Lab, China National Biotec, Serum Institute of India, Intervax, GSBPL etc. Top 3 companies occupied about 77% market share.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for BCG Vaccine, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global BCG Vaccine market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global BCG Vaccine market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, BCG Vaccine sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of BCG Vaccine covered in this report include Merck, Sanofi Pasteur, Japan BCG Lab, China National Biotec, Serum Institute of India, Intervax and GSBPL, etc.
The global BCG Vaccine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Merck
Sanofi Pasteur
Japan BCG Lab
China National Biotec
Serum Institute of India
Intervax
GSBPL
Global BCG Vaccine market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global BCG Vaccine market, Segment by Type:
Immune BCG
Therapy BCG
Global BCG Vaccine market, by Application
Hospitals
Clinics
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of BCG Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of BCG Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 BCG Vaccine Market Overview
1.1 BCG Vaccine Product Overview
1.2 BCG Vaccine Market Segment by Type
1.2.1 Immune BCG
1.2.2 Therapy BCG
1.3 Global BCG Vaccine Market Size by Type
1.3.1 Global BCG Vaccine Market Size Overview by Type (2018-2029)
1.3.2 Global BCG Vaccine Historic Market Size Review by Type (2018-2023)
1.3.3 Global BCG Vaccine Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America BCG Vaccine Sales Breakdown by Type (2018-2023)
1.4.2 Europe BCG Vaccine Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific BCG Vaccine Sales Breakdown by Type (2018-2023)
1.4.4 Latin America BCG Vaccine Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa BCG Vaccine Sales Breakdown by Type (2018-2023)
2 Global BCG Vaccine Market Competition by Company
2.1 Global Top Players by BCG Vaccine Sales (2018-2023)
2.2 Global Top Players by BCG Vaccine Revenue (2018-2023)
2.3 Global Top Players by BCG Vaccine Price (2018-2023)
2.4 Global Top Manufacturers BCG Vaccine Manufacturing Base Distribution, Sales Area, Product Type
2.5 BCG Vaccine Market Competitive Situation and Trends
2.5.1 BCG Vaccine Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by BCG Vaccine Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in BCG Vaccine as of 2022)
2.7 Date of Key Manufacturers Enter into BCG Vaccine Market
2.8 Key Manufacturers BCG Vaccine Product Offered
2.9 Mergers & Acquisitions, Expansion
3 BCG Vaccine Status and Outlook by Region
3.1 Global BCG Vaccine Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global BCG Vaccine Historic Market Size by Region
3.2.1 Global BCG Vaccine Sales in Volume by Region (2018-2023)
3.2.2 Global BCG Vaccine Sales in Value by Region (2018-2023)
3.2.3 Global BCG Vaccine Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global BCG Vaccine Forecasted Market Size by Region
3.3.1 Global BCG Vaccine Sales in Volume by Region (2024-2029)
3.3.2 Global BCG Vaccine Sales in Value by Region (2024-2029)
3.3.3 Global BCG Vaccine Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global BCG Vaccine by Application
4.1 BCG Vaccine Market Segment by Application
4.1.1 Hospitals
4.1.2 Clinics
4.1.3 Others
4.2 Global BCG Vaccine Market Size by Application
4.2.1 Global BCG Vaccine Market Size Overview by Application (2018-2029)
4.2.2 Global BCG Vaccine Historic Market Size Review by Application (2018-2023)
4.2.3 Global BCG Vaccine Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America BCG Vaccine Sales Breakdown by Application (2018-2023)
4.3.2 Europe BCG Vaccine Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific BCG Vaccine Sales Breakdown by Application (2018-2023)
4.3.4 Latin America BCG Vaccine Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa BCG Vaccine Sales Breakdown by Application (2018-2023)
5 North America BCG Vaccine by Country
5.1 North America BCG Vaccine Historic Market Size by Country
5.1.1 North America BCG Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America BCG Vaccine Sales in Volume by Country (2018-2023)
5.1.3 North America BCG Vaccine Sales in Value by Country (2018-2023)
5.2 North America BCG Vaccine Forecasted Market Size by Country
5.2.1 North America BCG Vaccine Sales in Volume by Country (2024-2029)
5.2.2 North America BCG Vaccine Sales in Value by Country (2024-2029)
6 Europe BCG Vaccine by Country
6.1 Europe BCG Vaccine Historic Market Size by Country
6.1.1 Europe BCG Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe BCG Vaccine Sales in Volume by Country (2018-2023)
6.1.3 Europe BCG Vaccine Sales in Value by Country (2018-2023)
6.2 Europe BCG Vaccine Forecasted Market Size by Country
6.2.1 Europe BCG Vaccine Sales in Volume by Country (2024-2029)
6.2.2 Europe BCG Vaccine Sales in Value by Country (2024-2029)
7 Asia-Pacific BCG Vaccine by Region
7.1 Asia-Pacific BCG Vaccine Historic Market Size by Region
7.1.1 Asia-Pacific BCG Vaccine Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific BCG Vaccine Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific BCG Vaccine Sales in Value by Region (2018-2023)
7.2 Asia-Pacific BCG Vaccine Forecasted Market Size by Region
7.2.1 Asia-Pacific BCG Vaccine Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific BCG Vaccine Sales in Value by Region (2024-2029)
8 Latin America BCG Vaccine by Country
8.1 Latin America BCG Vaccine Historic Market Size by Country
8.1.1 Latin America BCG Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America BCG Vaccine Sales in Volume by Country (2018-2023)
8.1.3 Latin America BCG Vaccine Sales in Value by Country (2018-2023)
8.2 Latin America BCG Vaccine Forecasted Market Size by Country
8.2.1 Latin America BCG Vaccine Sales in Volume by Country (2024-2029)
8.2.2 Latin America BCG Vaccine Sales in Value by Country (2024-2029)
9 Middle East and Africa BCG Vaccine by Country
9.1 Middle East and Africa BCG Vaccine Historic Market Size by Country
9.1.1 Middle East and Africa BCG Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa BCG Vaccine Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa BCG Vaccine Sales in Value by Country (2018-2023)
9.2 Middle East and Africa BCG Vaccine Forecasted Market Size by Country
9.2.1 Middle East and Africa BCG Vaccine Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa BCG Vaccine Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Merck
10.1.1 Merck Company Information
10.1.2 Merck Introduction and Business Overview
10.1.3 Merck BCG Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Merck BCG Vaccine Products Offered
10.1.5 Merck Recent Development
10.2 Sanofi Pasteur
10.2.1 Sanofi Pasteur Company Information
10.2.2 Sanofi Pasteur Introduction and Business Overview
10.2.3 Sanofi Pasteur BCG Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Sanofi Pasteur BCG Vaccine Products Offered
10.2.5 Sanofi Pasteur Recent Development
10.3 Japan BCG Lab
10.3.1 Japan BCG Lab Company Information
10.3.2 Japan BCG Lab Introduction and Business Overview
10.3.3 Japan BCG Lab BCG Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Japan BCG Lab BCG Vaccine Products Offered
10.3.5 Japan BCG Lab Recent Development
10.4 China National Biotec
10.4.1 China National Biotec Company Information
10.4.2 China National Biotec Introduction and Business Overview
10.4.3 China National Biotec BCG Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.4.4 China National Biotec BCG Vaccine Products Offered
10.4.5 China National Biotec Recent Development
10.5 Serum Institute of India
10.5.1 Serum Institute of India Company Information
10.5.2 Serum Institute of India Introduction and Business Overview
10.5.3 Serum Institute of India BCG Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Serum Institute of India BCG Vaccine Products Offered
10.5.5 Serum Institute of India Recent Development
10.6 Intervax
10.6.1 Intervax Company Information
10.6.2 Intervax Introduction and Business Overview
10.6.3 Intervax BCG Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Intervax BCG Vaccine Products Offered
10.6.5 Intervax Recent Development
10.7 GSBPL
10.7.1 GSBPL Company Information
10.7.2 GSBPL Introduction and Business Overview
10.7.3 GSBPL BCG Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.7.4 GSBPL BCG Vaccine Products Offered
10.7.5 GSBPL Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 BCG Vaccine Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 BCG Vaccine Industrial Chain Analysis
11.4 BCG Vaccine Market Dynamics
11.4.1 BCG Vaccine Industry Trends
11.4.2 BCG Vaccine Market Drivers
11.4.3 BCG Vaccine Market Challenges
11.4.4 BCG Vaccine Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 BCG Vaccine Distributors
12.3 BCG Vaccine Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
